Moreover, AMPK activation induced by AMPK activator negatively regulates the glycolysis-dependent metabolism in tamoxifen-resistant breast cancer cells by inhibiting mTOR/HIF-1α signaling. Here, HIF1A is linked to breast carcinoma.